【Urgent Request】European and American biotech companies are interested in licensing drugs for PD, AD and other CNS diseases

Project Code: BP-20240516-L-EE-104

Demand Party: #EuropeanBiotech and #AmericanBiotech

Therapeutic Area: #CNS (#CentralNervousSystem)

Indication: Parkinson’s Disease (#PD)、Alzheimer’s Disease (#AD) 、#MultipleSclerosis (MS)、#Epilepsy、#Migraine、#Schizophrenia、#Depression、#Anxiety Disorders、#BipolarDisorder、Amyotrophic Lateral Sclerosis (#ALS)、Huntington’s Disease (#HD) 、#BrainTumors、#Stroke. Please see below for more details.

Target/MOA: Innovative Target/Mechanism of Action (MOA)

Product Phase: Preclinical, Phase 1, Phase 2

Molecular Entity: Open

Rights: Global rights, open for discussions

Cooperation Model: Licensing

CNS indications:

1. Alzheimer’s Disease (AD) – A progressive neurodegenerative disorder causing memory loss and cognitive decline.
2. Parkinson’s Disease (PD) – A neurodegenerative disorder that affects movement, often causing tremors and difficulty with balance and coordination.
3. Multiple Sclerosis (MS) – A chronic disease that affects the brain and spinal cord, causing a wide range of symptoms including problems with muscle movement, coordination, and vision.
4. Epilepsy – A chronic disorder characterized by recurrent seizures, which are caused by abnormal electrical activity in the brain.
5. Migraine – A common neurological condition characterized by severe headaches and often accompanied by nausea, vomiting, and sensitivity to light and sound.
6. Schizophrenia – A chronic mental disorder characterized by abnormal thoughts, perceptions, and behaviors.
7. Depression – A mood disorder that affects a person’s thoughts, emotions, and behaviors, leading to feelings of sadness and hopelessness.
8. Anxiety Disorders – A group of mental disorders characterized by excessive and persistent worry or fear.
9. Bipolar Disorder – A mental health condition characterized by extreme mood swings that include emotional highs (mania or hypomania) and lows (depression).
10. Amyotrophic Lateral Sclerosis (ALS) – A progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control.
11. Huntington’s Disease (HD) – A hereditary neurodegenerative disorder that affects muscle coordination and leads to cognitive decline and psychiatric problems.
12. Brain Tumors – Abnormal growths of cells within the brain, which can be benign or malignant, and can cause a variety of symptoms depending on their location and size.
13. Stroke – A medical condition that occurs when the blood supply to a part of the brain is interrupted or reduced, depriving brain tissue of oxygen and nutrients.

If interested in this #licensing opportunity, please contact #DrugTimes BD Team at BD@drugtimes.cn.

Thank you very much!~

#Businessdevelopment #drugdiscovery #drugdevelopment #WorldBDDay #ChinaBiotech